Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 3/20 | 0.40 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | GRB2 | P62993 | 1/20 | 0.38 |
| ▸ | NTMT1 | Q9BV86 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 3/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28890650 | 1.00 | APLNR (0.40) | APLNRNAA50PTPN1GRB2NTMT1 | |
| SCHEMBL31544467 | 1.00 | APLNR (0.40) | APLNRNAA50PTPN1GRB2NTMT1 | |
| SCHEMBL4726312 | 1.00 | APLNR (0.40) | APLNRNAA50PTPN1GRB2NTMT1 | |
| SCHEMBL29832781 | 0.97 | APLNR (0.38) | APLNRNAA50PTPN1GRB2NTMT1 | |
| SCHEMBL4959057 | 0.94 | ACE (0.40) | APLNRNAA50NTMT1F2FAP | |
| SCHEMBL29832826 | 0.93 | PTPN1 (0.43) | APLNRNAA50PTPN1NTMT1F2 | |
| SCHEMBL31070022 | 0.93 | APLNR (0.42) | APLNRNAA50NTMT1F2FAP | |
| SCHEMBL4258292 | 0.92 | F2 (0.39) | APLNRNAA50PTPN1NTMT1F2 | |
| SCHEMBL30563305 | 0.92 | GRB2 (0.44) | PTPN1GRB2NTMT1F2 | |
| SCHEMBL28890641 | 0.92 | F2 (0.42) | GRB2NTMT1F2FAPITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105954-A1 | LIP COSMETIC MATERIAL COMPOSITION FOR IMPROVING LIP VOLUME AND AMELIORATING LIP WRINKLES | 이윤진 | 2026-05-21 | — | — | WO | claimed |
| CN-122031296-A | Emulsion for removing eye marks and preparation method thereof | 广东微肽生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4703370-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | Shenzhen Dikeman Biotechnology Co., Ltd. (CN) | 2026-03-04 | — | — | EP | claimed |
| CN-121570378-A | Polypeptide composition with functions of whitening and brightening skin, anti-inflammatory, anti-photoaging and skin repairing and application thereof | 山东济肽生物科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| WO-2025226919-A1 | SKIN CARE COMPOSITION COMPRISING PEPTIDE DERIVATIVE AND FATTY ACID, AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250332083-A1 | SKIN CARE COMPOSITION COMPRISING PEPTIDE DERIVATIVE AND FATTY ACID, AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-10-30 | — | — | US | claimed |
| CN-120154561-A | Eye cream containing caviar extract and preparation method thereof | 广东芬氏生物科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120114348-A | Application of composition in anti-inflammatory and cosmetic | 欧诗漫生物股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-119950345-A | Anti-wrinkle face cream | 广东丸美生物技术股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119548444-B | Breast enlarging composition containing natural plant extract and preparation method thereof | 广州市华侬化妆品股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-110711150-B | Preparation method and application of polypeptide liposome | 深圳市一支秀美生物科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114306128-A | Anti-aging and anti-firming composition and preparation method thereof | 广州盛妍精细化工有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114129490-A | Sea-buckthorn collagen anti-aging moisturizing mask and preparation method thereof | 贾非 | 2022-03-04 | — | — | CN | claimed |
| WO-2022043840-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN | ISP INVESTMENTS LLC (US) | 2022-03-03 | — | — | WO | claimed |
| CN-114099383-A | Soluble breast enhancement microneedle and preparation method thereof | 烟台魔技纳米科技有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-11260010-B2 | Cochelates using phosphatidylserine/anionic surfactant/calcium chloride | H&A PHARMACHEM CO., LTD (KR) | 2022-03-01 | — | — | US | claimed |
| CN-114081852-A | Compositions and methods for improving the appearance of skin | ISP投资有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-114073662-A | Intelligent care mother solution for eye and preparation method thereof | 广东长昊药业股份有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-114042003-A | Preparation method of repairing mask | 四川泊麦科技发展股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-114028315-A | Intelligent protection fish roe protein mother liquor and preparation method thereof | 广东长昊药业股份有限公司 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332083-A1 | SKIN CARE COMPOSITION COMPRISING PEPTIDE DERIVATIVE AND FATTY ACID, AND METHOD OF USING THE SAME | CUTA, QRFPR, ARGLU1 | APLNR 218/4885NAA50 3048/4885PTPN1 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.